Related Experiment Video
Updated: Sep 22, 2025
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
664
Noncoding RNA actions through IGFs and IGF binding proteins in cancer
1University of Sydney, Faculty of Medicine and Health, Kolling Institute, Royal North Shore Hospital, St Leonards, Sydney, NSW, 2065, Australia. aidan.kerr1998@gmail.com.
Oncogene
|May 21, 2022
Summary
This review explores how noncoding RNAs (ncRNAs) interact with insulin-like growth factors (IGFs) and their binding proteins in cancer. Understanding these links may reveal new cancer prognosis and therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) are crucial in cancer progression, affecting cell survival, proliferation, migration, angiogenesis, and metastasis.
- IGFBPs regulate the bioavailability of IGF-1 and IGF-2, impacting the type-1 IGF receptor (IGF1R) pathway and influencing cancer development through IGF-dependent and independent mechanisms.
- Noncoding RNAs (ncRNAs), including microRNAs (miRNAs) and long-noncoding RNAs (lncRNAs), are involved in oncogenic pathways, but their intersections with the IGF axis in cancer are not fully understood.
Purpose of the Study:
- To review the functional interactions between miRNAs and lncRNAs with IGFs and IGFBPs in the context of cancer.
- To elucidate how the IGF axis mediates ncRNA actions that either promote or suppress cancer development.
- To identify potential new avenues for cancer prognosis and therapeutic interventions by understanding the links between ncRNA and IGF pathways.
Main Methods:
- Literature review and synthesis of existing research on ncRNAs, IGFs, and IGFBPs in cancer.
- Analysis of functional interactions and signaling pathways involving these molecular players.
- Exploration of intersecting pathways in non-cancer conditions to inform cancer research.
Main Results:
- ncRNAs functionally interact with IGFs and their binding proteins, influencing cancer progression.
- The IGF axis plays a role in mediating the pro-cancer or anti-cancer effects of ncRNAs.
- Interactions between ncRNAs and the IGF axis are observed in various cancer types and may extend to non-cancerous conditions.
Conclusions:
- A deeper understanding of ncRNA-IGF axis interactions is essential for developing novel cancer biomarkers and therapeutic strategies.
- Exploring these pathways in both cancer and non-cancer conditions can uncover new opportunities for cancer control.
- Targeting the interplay between ncRNAs and the IGF system holds promise for future cancer treatment advancements.
Related Concept Videos
02:15Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:23RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K
02:39lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
01:16TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
02:30siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K